CHUC Charlie's Holdings, Inc.
Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1134765 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY266.1%
TTM net income YoY-222.5%
TTM EPS YoY-171.4%
Revenue 3-yr CAGR9.2%
Net income 3-yr CAGR—
Margins
Gross margin27.4%
Operating margin-10.8%
Net margin-7.9%
FCF margin—
EBITDA margin-10.7%
Returns
ROE-73.5%
ROA-20.9%
ROIC (approx.)-126.2%
Asset turnover2.63x
Leverage & solvency
Liabilities / assets75.5%
Debt / equity0.00x
Current ratio1.65x
Interest coverage-9.86x
Cash quality & payout
Operating cash flow / net income2.15x
Accruals ratio23.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $3.80M | $4.80M | $8.98M | $7.08M | $1.76M | $1.58M | $1.78M | $1.62M |
| Cost of revenue | $2.68M | $3.62M | $6.28M | $5.32M | $1.27M | $1.19M | $522,000 | $994,000 |
| Gross profit | $1.12M | $1.18M | $2.70M | $1.76M | $486,000 | $386,000 | $525,000 | $630,000 |
| SG&A expense | $1.92M | $1.74M | $2.14M | $1.69M | $1.36M | $1.09M | $1.33M | $1.42M |
| Operating income | -$1.23M | -$975,000 | -$123,000 | -$339,000 | -$954,000 | -$879,000 | -$899,000 | -$876,000 |
| Interest expense | $81,000 | $75,000 | $78,000 | $37,000 | $333,000 | $241,000 | $226,000 | $146,000 |
| Pretax income | -$1.66M | -$1.05M | -$201,000 | $624,000 | $5.31M | -$1.27M | -$969,000 | -$1.02M |
| Income tax | $0 | $0 | -$151,000 | $0 | $388,000 | $0 | $0 | $0 |
| Net income | -$1.66M | -$1.05M | $131,000 | $624,000 | $4.96M | -$1.22M | -$1.12M | -$1.02M |
| EBITDA | -$1.23M | -$969,000 | -$117,000 | -$331,000 | -$942,000 | -$866,000 | -$885,000 | -$852,000 |
| EPS (basic) | -0.01 | 0.00 | — | 0.00 | 0.02 | -0.01 | — | 0.00 |
| EPS (diluted) | — | — | — | 0.00 | 0.00 | 0.00 | — | 0.00 |
| Weighted avg. shares (diluted) | 274.07M | 268.13M | — | 277.56M | 281.98M | 253.57M | — | 242.57M |
| Balance sheet | ||||||||
| Cash & equivalents | $527,000 | $640,000 | $1.32M | $1.15M | $1.45M | $112,000 | $211,000 | $601,000 |
| Receivables | $452,000 | $1.27M | $440,000 | $1.15M | $379,000 | $17,000 | $331,000 | $84,000 |
| Inventory | $9.07M | $10.10M | $6.72M | $4.25M | $3.62M | $2.63M | $2.13M | $2.73M |
| Current assets | $11.99M | $14.12M | $10.77M | $9.84M | $5.85M | $3.00M | $3.72M | $3.94M |
| PP&E, net | $173,000 | $31,000 | $37,000 | $20,000 | $20,000 | $40,000 | $53,000 | $67,000 |
| Total assets | $12.79M | $14.85M | $11.56M | $10.56M | $5.97M | $3.17M | $3.94M | $4.22M |
| Current liabilities | $7.24M | $9.27M | $7.63M | $6.76M | $3.63M | $5.83M | $5.58M | $5.33M |
| Long-term debt | — | — | — | — | — | $3.14M | $2.16M | $2.57M |
| Total debt | — | — | — | — | — | $3.14M | $2.16M | $2.57M |
| Total liabilities | $9.66M | $11.74M | $8.14M | $7.32M | $3.79M | $5.98M | $5.72M | $5.48M |
| Shareholders' equity | $3.13M | $3.11M | $3.42M | $3.24M | $2.19M | -$2.81M | -$1.78M | -$1.26M |
| Net debt | — | — | — | — | — | $3.02M | $1.95M | $1.97M |
| Shares outstanding | 280.55M | 274.20M | 270.65M | 270.57M | 259.95M | 257.41M | 257.29M | 249.57M |
| Cash flow statement | ||||||||
| Operating cash flow | -$383,000 | -$1.10M | $394,000 | -$3.11M | -$2.65M | -$409,000 | -$377,000 | -$944,000 |
| Investing cash flow | — | — | -$23,000 | $1.00M | — | — | $0 | $0 |
| Financing cash flow | $270,000 | $425,000 | -$201,000 | $1.81M | -$2.50M | $310,000 | -$13,000 | $460,000 |
| Depreciation & amortization | $5,000 | $6,000 | $6,000 | $8,000 | $12,000 | $13,000 | $14,000 | $24,000 |
| Stock-based compensation | $18,000 | $25,000 | $53,000 | $55,000 | $38,000 | $40,000 | $57,000 | $56,000 |
Free plan shows the latest 8 periods; Pro shows all 67 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.